.Pharmacolibrary.Drugs.ATC.J.J07CA03 .Pharmacolibrary.Drugs.ATC.J.J07CA03| name: | DiphtheriaRubellaTetanus |
| ATC code: | J07CA03 | route: | intramuscular |
| n-compartments | 1 |
The diphtheria-rubella-tetanus (DRT) vaccine is a combined immunization used primarily to protect against three infectious diseases: diphtheria, caused by Corynebacterium diphtheriae; rubella, caused by rubella virus; and tetanus, caused by Clostridium tetani. This vaccine is widely used in routine childhood immunization schedules across the globe and is approved for use today to prevent these diseases.
There are no published pharmacokinetic (PK) models or quantitative PK parameters available for the diphtheria-rubella-tetanus vaccine in the literature. The vaccine consists of inactivated bacterial toxoids (diphtheria, tetanus) and live-attenuated virus (rubella) administered intramuscularly, and the pharmacokinetic evaluation is not typically performed for vaccines. The following parameters are not available and are left empty or default as appropriate.